Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Jul 19, 2022

SELL
$13.11 - $17.02 $9,347 - $12,135
-713 Reduced 2.46%
28,224 $402,000
Q1 2022

Apr 26, 2022

BUY
$15.35 - $19.29 $967 - $1,215
63 Added 0.22%
28,937 $479,000
Q4 2021

Feb 14, 2022

SELL
$18.5 - $21.59 $15,022 - $17,531
-812 Reduced 2.74%
28,874 $555,000
Q3 2021

Nov 12, 2021

BUY
$20.27 - $22.67 $770 - $861
38 Added 0.13%
29,686 $617,000
Q2 2021

Aug 13, 2021

BUY
$19.14 - $21.44 $1,914 - $2,144
100 Added 0.34%
29,648 $636,000
Q1 2021

May 17, 2021

BUY
$19.31 - $22.07 $570,571 - $652,124
29,548 New
29,548 $582,000

Others Institutions Holding HQL

About TEKLA LIFE SCIENCES INVESTORS


  • Ticker HQL
  • Exchange NYSE
  • Sector Financial Services
  • Industry Asset Management
  • Description
  • Tekla Life Sciences Investors is a closed-ended equity mutual fund launched and managed by Tekla Capital Management LLC. The fund invests in public equity markets across the globe. It seeks to invest in stocks of companies operating in the life sciences sector, including the biotechnology, pharmaceutical, diagnostics, managed healthcare, medical...
More about HQL
Track This Portfolio

Track Hennion & Walsh Asset Management, Inc. Portfolio

Follow Hennion & Walsh Asset Management, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hennion & Walsh Asset Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Hennion & Walsh Asset Management, Inc. with notifications on news.